CHRONIC MYELOID LEUKEMIA (CML)

Dr Waqar


NORMAL WBC FORMATION

img-0.jpeg


CML DEFINITION

  • It is a malignancy of WBCs in which there is excess production of myeloid cells (neutros., basophils & eosinophils). The cells are mature looking but functionally abnormal.

REMEMBER: AML vs CML

AML is also a malignancy of myeloid cells but:

  • It runs an acute course (rapid)
  • The leukemic cells are immature looking “blasts” (myeloblasts) & the cell of origin is an earlier precursor of WBCs

(remember, blast cell is always an immature cell & seen in acute leukemias)


SOME GENERAL POINTS

  • It has an insidious and gradual onset.
  • Occurs in middle to old age (around 55)
  • The cancer cells contain an abnormal chromosome called “Philadelphia chromosome” having the bcr/abl gene
  • In most cases, it is curable
  • The drug IMATINIB has revolutionized the treatment & prognosis

Ph chromosomes with bcr/abl gene

img-1.jpeg


EPIDEMIOLOGY

  • Age group: Middle to old age. Rare in children
  • Gender: Slightly more in males
  • Accounts for 8% of all leukemias in U.K.

PHASES OF CML

CML is classified into 3 phases, based on clinical features and lab findings:

PhaseCharacteristics
Chronic phaseInitial phase, slow-growing tumor
Accelerated phaseFaster cancer growth, rising WBC count
Blast crisisFinal phase, rapid progression, excess blast cells

CHRONIC PHASE

  • This is the initial phase & lasts for 3-4 yrs, if no treatment is given
  • Tumour grows slowly & gradually
  • Patients often asymptomatic initially & discovered on routine CBC (very high WBC)
  • Later, maybe fatigue, weight loss, night sweats, huge spleen causing abdominal heaviness
  • Fever, night sweats, recurrent infections
  • If treatment is not given, this progresses into the next phase

ACCELERATED PHASE

  • The cancer grows faster during this phase & WBC count rises fast
  • There are specific W.H.O. criteria for diagnosis of accelerated phase (increased number of basophils & blast cells, spleen size, etc.)

BLAST CRISIS

  • Final phase in the course of CML (if no treatment was given)
  • Cancer progresses very rapidly and quick death occurs (behaves like acute leukemia)
  • Excess “blast” cells can now be seen in the bone marrow & blood
  • Patients present with fever, anemia, bleeding, & infections (more severe now)

TREATMENT IMPACT ON PROGRESSION

If treatment is given during the chronic phase, it may stop the tumor progression into the next phases


SIGNS AND SYMPTOMS (S/S)

Depend on the phase of the disease at the time of diagnosis:

  • Asymptomatic
  • Fatigue, weakness, wt. loss, fever, night sweats
  • Splenomegaly ( often massive)
  • Hepatomegaly, lymph node enlargement
  • Features of anemia, bleeding & infections

DIAGNOSIS

1) Blood

  • Very high WBC count (usually >150,000)
  • High neutrophils, basophils & eosinophils (myeloid cells)
  • Low hemoglobin (Hb), low platelets

2) Bone Marrow

  • Hypercellular, with very high number of myeloid cells

BLOOD FILM

img-2.jpegimg-3.jpeg


BONE MARROW

img-4.jpeg

  • Note the excess myeloid series cells

3) Cytogenetics (Gene Analysis)

  • Leukemic cells have the Philadelphia chromosome (Ph chromosome) / bcr-abl gene

TREATMENT

1) Chronic Phase

  • Imatinib (tyrosine kinase inhibitor)
  • Introduced in 1999/2000. Very good survival rates with this drug (response in more than 95% of cases)
  • Given for 2 years, can be repeated for a relapse

2) Accelerated & Blast Phase

  • These phases are treated like acute leukemia (more aggressive treatment with other chemo drugs, plus imatinib)

PROGNOSIS

Greatly improved after “tyrosine kinase inhibitors”

Additional Treatment Options:

  • Bone marrow transplant/ Stem cell transplant